Conquering Diseases

Study Of An Investigational Drug For Maintenance Therapy Following Stem Cell Transplant For Multiple Myeloma

Description

Seeking adults with newly diagnosed Multiple Myeloma for a study of an investigational drug for maintenance therapy following stem cell transplant.

Overview

Participants in this study will be randomly selected to get either the investigational drug or the standard drug.

What we're hoping for

We are studying if an investigational drug is safe and if it is the same, better, or worse than the standard maintenance therapy drug following stem cell transplant for newly diagnosed Multiple Myeloma patients.

Additional Information

ClinicalTrials.gov Identifier: NCT05827016

 Principal Investigator

Muthalagu  Ramanathan, MD

UMass Memorial Health

 Study Contact

The Cancer  Research Office

508-856-3216

Cancer.research@umassmed.edu

 Location

UMMH Memorial Campus

119 Belmont St. 

Worcester,MA 01605

508-334-1000